A Novel Triplet of Alisertib Plus Ibrutinib Plus Rituximab Is Active in Mantle Cell Lymphoma

  • Baskaran Subramani
  • , Patrick J. Conway
  • , Aisha Al-Khinji
  • , Kun Zhang
  • , Ritu Pandey
  • , Daruka Mahadevan

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'A Novel Triplet of Alisertib Plus Ibrutinib Plus Rituximab Is Active in Mantle Cell Lymphoma'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science